This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 01/21/2021
Location: Virtual
Subject: Duke Human Vaccine Institute Webinar: Taking Science to the Streets
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia and other stakeholders

Event Date: 01/21/2021
Location: Virtual
Subject: Reagan-Udall Foundation: COVID-19 Evidence Accelerator Collaborative Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Academia, patient groups, industry, and other stakeholders

Event Date: 01/22/2021
Location: Virtual
Subject: Health Evolution Leadership Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Event Date: 01/22/2021
Location: Virtual
Subject: National Academy of Medicine Digital Health Sector Author Call
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and other stakeholders

Event Date: 01/22/2021
Location: Virtual
Subject: National Academy of Medicine Announces Committee on Emerging Science, Technology, and Innovation (CESTI) Regenerative Medicine Working Group Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, patient groups, industry, and other stakeholders

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Heidi Rebello, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research

Event Date: 01/20/2021
Location: Virtual
Subject: Meeting with Alzheimer's Association
FDA Participant/Group: N/A
Non FDA Participant/Group: Advocates and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/19/2021
Location: Virtual
Subject: Yale School of Medicine; Dean's Workshop: Network for Vaccine Initiatives at Yale
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia

Event Date: 01/22/2021
Location: Virtual
Subject: CureDuchenne Webinar; COVID-19 Vaccines - What the Duchenne Community Needs to Know
FDA Participant/Group: N/A
Non FDA Participant/Group: CureDuchenne Community

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date: 01/19/2021
Location: Virtual
Subject: Arkansas Bioinformatics Consortium Governace Board Meeting
FDA Participant/Group: WEIDA TONG; TANMAY BERA;
Non FDA Participant/Group: Industry and academia

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event